The six-month rPFS rate and median rPFS for patients from both arms combined was 67% and 9.1 months, respectively. For patients treated with 120 mg gedatolisib, the six-month rPFS rate was 74% and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback